Search
15 Sept 2025
Search
15 Sept 2025
Please allow ads as they help fund our trusted local news content.
Kindly add us to your ad blocker whitelist.
If you want further access to Ireland's best local journalism, consider contributing and/or subscribing to our free daily Newsletter .
Support our mission and join our community now.
To continue reading this article, you can subscribe for as little as €0.50 per week which will also give you access to all of our premium content and archived articles!
Alternatively, you can pay €0.50 per article, capped at €1 per day.
Thank you for supporting Ireland's best local journalism!
An aerial view of the MSD pharmaceutical plant at Ballydine, Kilsheelan
Pharmaceutical giant MSD that operates a plant at Ballydine between Kilsheelan and Carrick-on-Suir has announced $3bn (€2.59bn) in global cost cuts as it prepares for generic competition to its cancer drug Keytruda.
Keytruda is the the world's best-selling medicine, which is predominantly made in Ireland.
READ ALSO: Gardaí appeal for witnesses following alleged assault in Tipperary
The company will cut administrative, sales and research jobs, with increased focus on the US market.
It's not known yet where the jobs will be lost and if any of its Irish workforce will be affected.
MSD employs more than 3,000 people at eight locations in Ireland, including MSD Ballydine, which was the company's first Irish factory. The other factories are MSD Brinny, Co. Cork, MSD Biotech, MSD Blackrock and MSD Red Oak North in Dublin, MSD Carlow, MSD Dunboyne in Co. Meath and MSD Dundalk.
READ NEXT: Design team to assess new site for Tipperary community nursing unit
Subscribe or register today to discover more from DonegalLive.ie
Buy the e-paper of the Donegal Democrat, Donegal People's Press, Donegal Post and Inish Times here for instant access to Donegal's premier news titles.
Keep up with the latest news from Donegal with our daily newsletter featuring the most important stories of the day delivered to your inbox every evening at 5pm.
This publication supports the work of the Press Council of Ireland and Office of the Press Ombudsman, and our staff operate within the Code of Practice of the Press Council. You can obtain a copy of the Code, or contact the Council, at www.presscouncil.ie, Lo-call 1800 208 080 or email: info@presscouncil.ie.
